Literature DB >> 18668687

The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor.

Tamara Frankenberg1, Tamir Miloh, Frank Y Chen, Meena Ananthanarayanan, An-Qiang Sun, Natarajan Balasubramaniyan, Irwin Arias, Kenneth D R Setchell, Frederick J Suchy, Benjamin L Shneider.   

Abstract

UNLABELLED: Prior loss-of-function analyses revealed that ATPase class I type 8B member 1 [familial intrahepatic cholestasis 1 (FIC1)] posttranslationally activated the farnesoid X receptor (FXR). Mechanisms underlying this regulation were examined by gain-of-function studies in UPS cells, which lack endogenous FIC1 expression. FXR function was assayed in response to wild-type and mutated FIC1 expression constructs with a human bile salt export pump (BSEP) promoter and a variety of cellular localization techniques. FIC1 overexpression led to enhanced phosphorylation and nuclear localization of FXR that was associated with FXR-dependent activation of the BSEP promoter. The FIC1 effect was lost after mutation of the FXR response element in the BSEP promoter. Despite similar levels of FIC1 protein expression, Byler disease FIC1 mutants did not activate BSEP, whereas benign recurrent intrahepatic cholestasis mutants partially activated BSEP. The FIC1 effect was dependent on the presence of the FXR ligand, chenodeoxycholic acid. The effect of FIC1 on FXR phosphorylation and nuclear localization and its effects on BSEP promoter activity could be blocked with protein kinase C zeta (PKC zeta) inhibitors (pseudosubstrate or small interfering RNA silencing). Recombinant PKC zeta directly phosphorylated immunoprecipitated FXR. The mutation of threonine 442 of FXR to alanine yielded a dominant negative protein, whereas the phosphomimetic conversion to glutamate resulted in FXR with enhanced activity and nuclear localization. Inhibition of PKC zeta in Caco-2 cells resulted in activation of the human apical sodium-dependent bile acid transporter promoter.
CONCLUSION: These results demonstrate that FIC1 signals to FXR via PKC zeta. FIC1-related liver disease is likely related to downstream effects of FXR on bile acid homeostasis. Benign recurrent intrahepatic cholestasis emanates from a partially functional FIC1 protein. Phosphorylation of FXR is an important mechanism for regulating its activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668687      PMCID: PMC2774894          DOI: 10.1002/hep.22431

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  53 in total

1.  Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation.

Authors:  Christine Demeilliers; Emmanuel Jacquemin; Véronique Barbu; Martine Mergey; François Paye; Laura Fouassier; Nicolas Chignard; Chantal Housset; Nour-Eddine Lomri
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

Review 2.  FIC1 disease: a spectrum of intrahepatic cholestatic disorders.

Authors:  S W van Mil; L W Klomp; L N Bull; R H Houwen
Journal:  Semin Liver Dis       Date:  2001-11       Impact factor: 6.115

3.  Immunoprecipitation of proteins from cell-free translations.

Authors:  D J Anderson; G Blobel
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.

Authors:  H Wang; J Chen; K Hollister; L C Sowers; B M Forman
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

5.  Atypical PKC-zeta and PKC-iota mediate opposing effects on MCF-7 Na+/K+ATPase activity.

Authors:  Antonella Muscella; Carlo Storelli; Santo Marsigliante
Journal:  J Cell Physiol       Date:  2005-11       Impact factor: 6.384

6.  Identification of a nuclear receptor for bile acids.

Authors:  M Makishima; A Y Okamoto; J J Repa; H Tu; R M Learned; A Luk; M V Hull; K D Lustig; D J Mangelsdorf; B Shan
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

7.  Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum.

Authors:  Nancy A M van Ooteghem; Leo W J Klomp; Gerard P van Berge-Henegouwen; Roderick H J Houwen
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

8.  Cross-talk between protein kinases Czeta and B in cyclic AMP-mediated sodium taurocholate co-transporting polypeptide translocation in hepatocytes.

Authors:  Marie McConkey; Henry Gillin; Cynthia R L Webster; M Sawkat Anwer
Journal:  J Biol Chem       Date:  2004-03-08       Impact factor: 5.157

9.  ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity.

Authors:  Coen C Paulusma; Dineke E Folmer; Kam S Ho-Mok; D Rudi de Waart; Petra M Hilarius; Arthur J Verhoeven; Ronald P J Oude Elferink
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.

Authors:  Takeshi Inagaki; Antonio Moschetta; Youn-Kyoung Lee; Li Peng; Guixiang Zhao; Michael Downes; Ruth T Yu; John M Shelton; James A Richardson; Joyce J Repa; David J Mangelsdorf; Steven A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

View more
  38 in total

Review 1.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 2.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 3.  FXR and PXR: potential therapeutic targets in cholestasis.

Authors:  Johan W Jonker; Christopher Liddle; Michael Downes
Journal:  J Steroid Biochem Mol Biol       Date:  2011-07-20       Impact factor: 4.292

Review 4.  Progressive familial intrahepatic cholestasis.

Authors:  Anshu Srivastava
Journal:  J Clin Exp Hepatol       Date:  2013-11-23

5.  Bile acids as global regulators of hepatic nutrient metabolism.

Authors:  Phillip B Hylemon; Kazuaki Takabe; Mikhail Dozmorov; Masayuki Nagahashi; Huiping Zhou
Journal:  Liver Res       Date:  2017-04-26

6.  Direct methylation of FXR by Set7/9, a lysine methyltransferase, regulates the expression of FXR target genes.

Authors:  Natarajan Balasubramaniyan; Meena Ananthanarayanan; Frederick J Suchy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-16       Impact factor: 4.052

Review 7.  Bile acids are nutrient signaling hormones.

Authors:  Huiping Zhou; Phillip B Hylemon
Journal:  Steroids       Date:  2014-05-10       Impact factor: 2.668

8.  Poly(ADP-ribose) polymerase 1 promotes oxidative-stress-induced liver cell death via suppressing farnesoid X receptor α.

Authors:  Cheng Wang; Fengxiao Zhang; Lin Wang; Yanqing Zhang; Xiangrao Li; Kun Huang; Meng Du; Fangmei Liu; Shizheng Huang; Youfei Guan; Dan Huang; Kai Huang
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

9.  FIC1-mediated stimulation of FXR activity is decreased with PFIC1 mutations in HepG2 cells.

Authors:  Saori Koh; Tappei Takada; Ikuya Kukuu; Hiroshi Suzuki
Journal:  J Gastroenterol       Date:  2009-04-21       Impact factor: 7.527

10.  Modulation of ileal apical Na+-dependent bile acid transporter ASBT by protein kinase C.

Authors:  Zaheer Sarwar; Fadi Annaba; Alka Dwivedi; Seema Saksena; Ravinder K Gill; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-01       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.